Re: Help needed on AMT

[Steve Mynott <steve@xxxxxxxxxxxxxxxxxxxxx>]

murple@xxxxxxxxxx writes:

> Again, I'd have to disagree. Although people have claimed AET (like AMT)
> is similar to MDMA, I think much of that is wishful thinking. In my
> experience, no tryptamines are similar to MDMA in any but the most
> superficial ways. AMT and AET are both "typical" tryptamines, and have far
> more in common with LSD or psilocybin than with MDMA.

AET is unlikely (at low doses anyway) to resemble LSD or psilocybin
since it was legally prescribed in many countries as an antidepressant
(Monase as the acetate salt from Upjohn).

If it were obviousily LSD-like it wouldn't have been approved for
clinical use in the first place.  Phenylethylamines like mescaline can
resemble tryptamines like LSD so I don't see why tryptamines like AET
can't resemble phenylethylamines like MDMA.

Shulgin's reported descriptions in TIHKAL state its MDMA-like, see:

<http://www.erowid.org/library/books_online/tihkal/tihkal11.shtml>

He says it has even been sold illegally as a MDMA substitute.

There are at least two journal references in support of the idea that
AET resembles MDMA.

AUTHOR:  Krebs KM; Geyer MA
TITLE: Behavioral characterization of alpha-ethyltryptamine, a
tryptamine derivative with MDMA-like properties in rats.
SOURCE:  Psychopharmacology (Berl) (QGI), 1993; 113 (2): 284-7

AUTHOR:  Glennon RA
TITLE:  MDMA-like stimulus effects of alpha-ethyltryptamine and the
alpha-ethyl homolog of DOM.
SOURCE:  Pharmacol Biochem Behav (P3Q), 1993 Oct; 46 (2): 459-62

AET also appears to be neurotoxic in the same way as MDMA and totally
unlike LSD.


-- 
Steve Mynott <steve@xxxxxxxxxxxxxxxxxxxxx>

-----------------
MAPS-Forum@xxxxxxxx, a member service of the Multidisciplinary Association
for Psychedelic Studies (see www.maps.org/memsub.html).
To [un]subscribe, email the message text,
[un]subscribe maps-forum youraddress to majordomo@xxxxxxxx
List archives: www.cerebral.org/Maps
Guidelines for authors: www.maps.org/guidelines.txt
MAPS Forum is supported by a generous grant from the Promind Foundation.